BLUE logo

Bluebird Bio (BLUE) Cash From Operations

Annual CFO

-$235.05 M
+$81.17 M+25.67%

December 31, 2023

Summary

Performance

1-Year Change

+25.67%

3-Year Change

+50.03%

5-Year Change

+43.15%

15-Year Change

+16.22%

BLUE Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

4.21%
BLUE annual cash flow from operations is higher than 4.21% of companies in Healthcare sector

High & Low

All-time High

$43.45 M
BLUE annual cash flow from operations is currently -640.96% below its historical high of $43.45 million

3-Year Low

-$635.64 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
BLUE previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 26, 2025
BLUE next annual earnings announcement is scheduled for Mar 26, 2025

OtherBLUEcash flowmetrics:

Annual CFI

$154.95 M
BLUE annual cash flow from investing activities is $154.95 million

Annual CFF

$196.25 M
BLUE annual cash flow from financing activities is $196.25 million

Annual FCF

-$244.10 M
BLUE annual free cash flow is -$244.10 million

Annual CAPEX

$9.06 M
BLUE annual capital expenditures is $9.06 million

Quarterly CFO

-$68.93 M
-$2.68 M-4.04%

September 30, 2024

Summary

Performance

3-Month Change

-4.04%

1-Year Change

+7.7%

3-Year Change

-252.77%

5-Year Change

+39.21%

BLUE Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

4%
BLUE quarterly cash flow from operations is higher than 4% of companies in Healthcare sector

High & Low

All-time High

$66.02 M
BLUE quarterly cash flow from operations is currently -204.41% below its historical high of $66.02 million

3-Year Low

-$139.72 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BLUE previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 26, 2025
BLUE next earnings announcement is scheduled for Mar 26, 2025

OtherBLUEcash flowmetrics:

Quarterly CFI

$466.00 K
BLUE quarterly cash flow from investing activities is $466.00 thousand

Quarterly CFF

-$6.11 M
BLUE quarterly cash flow from financing activities is -$6.11 million

Quarterly FCF

-$69.21 M
BLUE quarterly free cash flow is -$69.21 million

Quarterly CAPEX

$280.00 K
BLUE quarterly capital expenditures is $280.00 thousand

TTM CFO

-$263.99 M
-$18.88 M-7.70%

September 30, 2024

Summary

Performance

3-Month Change

-7.7%

1-Year Change

-10.75%

3-Year Change

+16.52%

5-Year Change

+59.57%

BLUE TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

3.22%
BLUE TTM cash flow from operations is higher than 3.22% of companies in Healthcare sector

High & Low

All-time High

$51.17 M
BLUE TTM cash flow from operations is currently -615.87% below its historical high of $51.17 million

3-Year Low

-$635.64 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BLUE previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 26, 2025
BLUE next earnings announcement is scheduled for Mar 26, 2025

OtherBLUEcash flowmetrics:

TTM CFI

$5.22 M
BLUE TTM cash flow from investing activities is $5.22 million

TTM CFF

$159.06 M
BLUE TTM cash flow from financing activities is $159.06 million

TTM FCF

-$271.32 M
BLUE TTM free cash flow is -$271.32 million

TTM CAPEX

$7.33 M
BLUE TTM capital expenditures is $7.33 million

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

BLUE Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+25.7%+7.7%-10.8%
3 y3 years+50.0%-252.8%+16.5%
5 y5 years+43.1%+39.2%+59.6%

BLUE Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+63.0%-252.8%+50.7%-31.7%+58.5%
5 y5-yearat high+63.0%-273.4%+66.6%-31.7%+59.6%
alltimeall time-641.0%+63.0%-204.4%+66.6%-615.9%+59.6%

Bluebird Bio Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$68.93 M(+4.0%)
-$263.99 M(+7.7%)
Jun 2024
-
-$66.25 M(-11.3%)
-$245.12 M(+2.8%)
Mar 2024
-
-$74.68 M(+37.9%)
-$238.36 M(+1.4%)
Dec 2023
-$235.05 M(-25.7%)
-$54.14 M(+8.2%)
-$235.05 M(+17.3%)
Sep 2023
-
-$50.05 M(-15.9%)
-$200.45 M(-11.9%)
Jun 2023
-
-$59.50 M(-16.6%)
-$227.42 M(-13.3%)
Mar 2023
-
-$71.36 M(+265.2%)
-$262.28 M(-17.1%)
Dec 2022
-$316.22 M(-50.3%)
-$19.54 M(-74.6%)
-$316.22 M(-27.5%)
Sep 2022
-
-$77.03 M(-18.4%)
-$436.40 M(-13.8%)
Jun 2022
-
-$94.36 M(-24.7%)
-$506.32 M(-9.2%)
Mar 2022
-
-$125.30 M(-10.3%)
-$557.61 M(-12.3%)
Dec 2021
-$635.64 M(+35.1%)
-$139.72 M(-4.9%)
-$635.64 M(-2.4%)
Sep 2021
-
-$146.94 M(+0.9%)
-$651.11 M(-0.3%)
Jun 2021
-
-$145.65 M(-28.4%)
-$652.95 M(+39.7%)
Mar 2021
-
-$203.33 M(+31.0%)
-$467.56 M(-0.6%)
Dec 2020
-$470.35 M(-16.7%)
-$155.19 M(+4.3%)
-$470.35 M(-0.8%)
Sep 2020
-
-$148.78 M(-474.4%)
-$474.13 M(+8.1%)
Jun 2020
-
$39.74 M(-119.3%)
-$438.74 M(-28.8%)
Mar 2020
-
-$206.12 M(+29.7%)
-$616.35 M(+9.2%)
Dec 2019
-$564.38 M(+36.5%)
-$158.98 M(+40.2%)
-$564.38 M(+5.5%)
Sep 2019
-
-$113.38 M(-17.8%)
-$535.14 M(+7.8%)
Jun 2019
-
-$137.87 M(-10.6%)
-$496.23 M(+8.2%)
Mar 2019
-
-$154.15 M(+18.8%)
-$458.76 M(+11.0%)
Dec 2018
-$413.43 M
-$129.73 M(+74.2%)
-$413.43 M(+9.1%)
Sep 2018
-
-$74.47 M(-25.8%)
-$379.07 M(+5.0%)
Jun 2018
-
-$100.40 M(-7.7%)
-$360.94 M(+14.9%)
DateAnnualQuarterlyTTM
Mar 2018
-
-$108.82 M(+14.1%)
-$314.07 M(+11.9%)
Dec 2017
-$280.55 M(+47.9%)
-$95.38 M(+69.3%)
-$280.55 M(+10.3%)
Sep 2017
-
-$56.34 M(+5.2%)
-$254.28 M(+7.1%)
Jun 2017
-
-$53.53 M(-28.9%)
-$237.38 M(+4.0%)
Mar 2017
-
-$75.30 M(+9.0%)
-$228.18 M(+20.3%)
Dec 2016
-$189.65 M(+92.7%)
-$69.11 M(+75.2%)
-$189.65 M(+23.4%)
Sep 2016
-
-$39.44 M(-11.0%)
-$153.63 M(+7.2%)
Jun 2016
-
-$44.33 M(+20.6%)
-$143.25 M(+29.0%)
Mar 2016
-
-$36.77 M(+11.1%)
-$111.04 M(+12.8%)
Dec 2015
-$98.43 M(+64.9%)
-$33.09 M(+13.8%)
-$98.43 M(+21.5%)
Sep 2015
-
-$29.07 M(+139.9%)
-$81.01 M(+11.4%)
Jun 2015
-
-$12.12 M(-49.8%)
-$72.71 M(+1.1%)
Mar 2015
-
-$24.16 M(+54.2%)
-$71.92 M(+20.5%)
Dec 2014
-$59.69 M(-237.4%)
-$15.66 M(-24.6%)
-$59.69 M(+20.6%)
Sep 2014
-
-$20.77 M(+83.4%)
-$49.48 M(+31.7%)
Jun 2014
-
-$11.32 M(-5.1%)
-$37.57 M(+8.9%)
Mar 2014
-
-$11.93 M(+118.8%)
-$34.50 M(-179.4%)
Dec 2013
$43.45 M(-306.5%)
-$5.46 M(-38.4%)
$43.45 M(+2.8%)
Sep 2013
-
-$8.86 M(+7.4%)
$42.27 M(-9.9%)
Jun 2013
-
-$8.25 M(-112.5%)
$46.91 M(-8.3%)
Mar 2013
-
$66.02 M(-1094.8%)
$51.17 M(-343.2%)
Dec 2012
-$21.04 M(+72.3%)
-$6.64 M(+57.1%)
-$21.04 M(+46.1%)
Sep 2012
-
-$4.22 M(+6.0%)
-$14.41 M(+41.5%)
Jun 2012
-
-$3.98 M(-35.7%)
-$10.19 M(+64.3%)
Mar 2012
-
-$6.20 M
-$6.20 M
Dec 2011
-$12.22 M
-
-

FAQ

  • What is bluebird bio annual cash flow from operations?
  • What is the all time high annual CFO for bluebird bio?
  • What is bluebird bio annual CFO year-on-year change?
  • What is bluebird bio quarterly cash flow from operations?
  • What is the all time high quarterly CFO for bluebird bio?
  • What is bluebird bio quarterly CFO year-on-year change?
  • What is bluebird bio TTM cash flow from operations?
  • What is the all time high TTM CFO for bluebird bio?
  • What is bluebird bio TTM CFO year-on-year change?

What is bluebird bio annual cash flow from operations?

The current annual CFO of BLUE is -$235.05 M

What is the all time high annual CFO for bluebird bio?

bluebird bio all-time high annual cash flow from operations is $43.45 M

What is bluebird bio annual CFO year-on-year change?

Over the past year, BLUE annual cash flow from operations has changed by +$81.17 M (+25.67%)

What is bluebird bio quarterly cash flow from operations?

The current quarterly CFO of BLUE is -$68.93 M

What is the all time high quarterly CFO for bluebird bio?

bluebird bio all-time high quarterly cash flow from operations is $66.02 M

What is bluebird bio quarterly CFO year-on-year change?

Over the past year, BLUE quarterly cash flow from operations has changed by +$5.75 M (+7.70%)

What is bluebird bio TTM cash flow from operations?

The current TTM CFO of BLUE is -$263.99 M

What is the all time high TTM CFO for bluebird bio?

bluebird bio all-time high TTM cash flow from operations is $51.17 M

What is bluebird bio TTM CFO year-on-year change?

Over the past year, BLUE TTM cash flow from operations has changed by -$25.63 M (-10.75%)